Glucocorticoid regulation of a novel HPV-E6-p53- MiR-145 pathway modulates invasion and therapy resistance of cervical cancer cells

Journal of Pathology

Volumn 228, Issue 2, 2012, Pages 148-157

  Shi, Ming ^a   Du, Libin ^b   Liu, Dan ^c   Qian, Lu ^a   Hu, Meiru ^a   Yu, Ming ^a   Yang, Zhengyan ^b   Zhao, Mingzhen ^b   Chen, Changguo ^a   Guo, Liang ^a   Wang, Lina ^d   Song, Lun ^a   Ma, Yuanfang ^b   Guo, Ning ^a  

^a INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

^b HENAN UNIVERSITY   (China)

^c HEBEI MEDICAL UNIVERSITY   (China)

^d Zhejiang Corps Hospital of Armed Police Force   (China)

Author keywords

cervical cancer; chemoresistance; glucocorticoids; HPV; miR 145; p53; stress

Indexed keywords

HYDROCORTISONE; MICRORNA 145; MITOMYCIN; PROTEIN E6; PROTEIN P53;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER INVASION; CANCER RESISTANCE; CELL MOTILITY; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; DRUG SENSITIVITY; FEMALE; FLOW CYTOMETRY; HELA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; INHIBITION KINETICS; MOLECULAR DYNAMICS; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UTERINE CERVIX CANCER; WART VIRUS; WESTERN BLOTTING; WILD TYPE;

ADENOCARCINOMA; ANTI-INFLAMMATORY AGENTS; APOPTOSIS; BLOTTING, NORTHERN; CELL MIGRATION ASSAYS; DOWN-REGULATION; DRUG RESISTANCE, NEOPLASM; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; HELA CELLS; HUMANS; HYDROCORTISONE; MICRORNAS; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRUS INFECTIONS; REAL-TIME POLYMERASE CHAIN REACTION; TRANSFECTION; TUMOR SUPPRESSOR PROTEIN P53; UTERINE CERVICAL NEOPLASMS;

EID: 84866248074     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.3997     Document Type: Article

References (41)

1. Walboomers JM, Jacobs MV, Manos MM, et al., Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999; 189: 12-19.
2. Moody CA, Laimins LA,. Human papillomavirus oncoproteins: pathways to transformation. Nat Rev Cancer 10: 550-560.
3. Herr I, Pfitzenmaier J,. Glucocorticoid use in prostate cancer and other solid tumours: implications for effectiveness of cytotoxic treatment and metastases. Lancet Oncol 2006; 7: 425-430.
4. Bromberg-White JL, Meyers C,. Comparison of the basal and glucocorticoid-inducible activities of the upstream regulatory regions of HPV18 and HPV31 in multiple epithelial cell lines. Virology 2003; 306: 197-202.
5. Mittal R, Pater A, Pater MM,. Multiple human papillomavirus type 16 glucocorticoid response elements functional for transformation, transient expression, and DNA-protein interactions. J Virol 1993; 67: 5656-5659.
6. Gloss B, Bernard HU, Seedorf K, et al., The upstream regulatory region of the human papilloma virus-16 contains an E2 protein-independent enhancer which is specific for cervical carcinoma cells and regulated by glucocorticoid hormones. EMBO J 1987; 6: 3735-3743.
7. Tang S, Tao M, McCoy JP, Jr, et al., Short-term induction and long-term suppression of HPV16 oncogene silencing by RNA interference in cervical cancer cells. Oncogene 2006; 25: 2094-2104.
8. Tang Sp, Tao Mp, McCoy JPJp, et al., The E7 oncoprotein is translated from spliced E6I transcripts in high-risk human papillomavirus type 16- or type 18-positive cervical cancer cell lines via translation reinitiation. J Virol 2006; 80: 4249-4263.
9. Sachdeva M, Mo YY,. miR-145-mediated suppression of cell growth, invasion and metastasis. Am J Transl Res 2: 170-180.
10. Sachdeva M, Zhu S, Wu F, et al., p53 represses c-Myc through induction of the tumor suppressor miR-145. Proc Natl Acad Sci USA 2009; 106: 3207-3212.
11. Suzuki HI, Yamagata K, Sugimoto K, et al., Modulation of microRNA processing by p53. Nature 2009; 460: 529-533.
12. Wang X, Tang S, Le SY, et al., Aberrant expression of oncogenic and tumor-suppressive microRNAs in cervical cancer is required for cancer cell growth. PLoS One 2008; 3: e2557.
13. Scheffner M, Werness BA, Huibregtse JM, et al., The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 1990; 63: 1129-1136.
14. Kamradt MC, Mohideen N, Krueger E, et al., Inhibition of radiation-induced apoptosis by dexamethasone in cervical carcinoma cell lines depends upon increased HPV E6/E7. Br J Cancer 2000; 82: 1709-1716.
15. Shi B, Sepp-Lorenzino L, Prisco M, et al., MicroRNA 145 targets the insulin receptor substrate-1 and inhibits the growth of colon cancer cells. J Biol Chem 2007; 282: 32582-32590.
16. La Rocca G, Shi B, Badin M, et al., Growth inhibition by microRNAs that target the insulin receptor substrate-1. Cell Cycle 2009; 8: 2255-2259.
17. Berns A,. Cancer: The blind spot of p53. Nature 468: 519-520.
18. Oren M,. Decision making by p53: life, death and cancer. Cell Death Differ 2003; 10: 431-442.
19. Vogelstein B, Lane D, Levine AJ,. Surfing the p53 network. Nature 2000; 408: 307-310.
20. Vousden KH, Lane DP,. p53 in health and disease. Nat Rev Mol Cell Biol 2007; 8: 275-283.
21. Brown BD, Gentner B, Cantore A, et al., Endogenous microRNA can be broadly exploited to regulate transgene expression according to tissue, lineage and differentiation state. Nat Biotechnol 2007; 25: 1457-1467.
22. Sarasin-Filipowicz M, Krol J, Markiewicz I, et al., Decreased levels of microRNA miR-122 in individuals with hepatitis C responding poorly to interferon therapy. Nat Med 2009; 15: 31-33.
23. Herr I, Gassler N, Friess H, et al., Regulation of differential pro- and anti-apoptotic signaling by glucocorticoids. Apoptosis 2007; 12: 271-291.
24. Boamah EK, White DE, Talbott KE, et al., Mitomycin-DNA adducts induce p53-dependent and p53-independent cell death pathways. ACS Chem Biol 2007; 2: 399-407.
25. Sachdeva M, Mo YY,. MicroRNA-145 suppresses cell invasion and metastasis by directly targeting mucin 1. Cancer Res 70: 378-387.
26. Sachdeva M, Mo YY,. p53 and c-myc: how does the cell balance 'yin' and 'yang'? Cell Cycle 2009; 8: 1303.
27. Baserga R,. The insulin receptor substrate-1: a biomarker for cancer? Exp Cell Res 2009; 315: 727-732.
28. Wei X, Xu H, Kufe D,. Human mucin 1 oncoprotein represses transcription of the p53 tumor suppressor gene. Cancer Res 2007; 67: 1853-1858.
29. Antoni MH, Lutgendorf SK, Cole SW, et al., The influence of bio-behavioural factors on tumour biology: pathways and mechanisms. Nat Rev Cancer 2006; 6: 240-248.
30. Giese-Davis J, Wilhelm FH, Conrad A, et al., Depression and stress reactivity in metastatic breast cancer. Psychosom Med 2006; 68: 675-683.
31. Sephton SE, Sapolsky RM, Kraemer HC, et al., Diurnal cortisol rhythm as a predictor of breast cancer survival. J Natl Cancer Inst 2000; 92: 994-1000.
32. Thornton LM, Andersen BL, Blakely WP,. The pain, depression, and fatigue symptom cluster in advanced breast cancer: covariation with the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. Health Psychol 29: 333-337.
33. Carlson LE, Campbell TS, Garland SN, et al., Associations among salivary cortisol, melatonin, catecholamines, sleep quality and stress in women with breast cancer and healthy controls. J Behav Med 2007; 30: 45-58.
34. Rutz HP,. Effects of corticosteroid use on treatment of solid tumours. Lancet 2002; 360: 1969-1970.
35. 1 cell cycle arrest. Mol Cell Biol 2005; 25: 7423-7431.
36. Ngan HY, Cheung AN, Liu SS, et al., Abnormal expression of pan-ras, c-myc and tp53 in squamous cell carcinoma of cervix: correlation with HPV and prognosis. Oncol Rep 2001; 8: 557-561.
37. Shang L, Zhou H, Xia Y, et al., Serum withdrawal up-regulates human SIRT1 gene expression in a p53-dependent manner. J Cell Mol Med 2009; 13: 4176-4184.
38. Menssen A, Hydbring P, Kapelle K, et al., The c-MYC oncoprotein, the NAMPT enzyme, the SIRT1-inhibitor DBC1, and the SIRT1 deacetylase form a positive feedback loop. Proc Natl Acad Sci USA 2012; 109: E187-96.
39. Zheng ZM, Wang X,. Regulation of cellular miRNA expression by human papillomaviruses. Biochim Biophys Acta 2011; 1809: 668-677.
40. Jeon JH, Kim SK, Kim HJ, et al., Insulin-like growth factor-1 attenuates cisplatin-induced γH2AX formation and DNA double-strand breaks repair pathway in non-small cell lung cancer. Cancer Lett 2008; 272: 232-241.
41. Ohlsson C, Kley N, Werner H, et al., p53 regulates insulin-like growth factor-I (IGF-I) receptor expression and IGF-I-induced tyrosine phosphorylation in an osteosarcoma cell line: interaction between p53 and Sp1. Endocrinology 1998; 139: 1101-1107.